@incollection{Wilke2016, author = {Wilke, Thomas}, title = {Planning Process of the Di Castellamonte's Chapel of the Holy Shroud}, series = {Carlo e Amedeo di Castellamonte : 1571-1683, ingegneri e architetti per i duchi di Savoia}, booktitle = {Carlo e Amedeo di Castellamonte : 1571-1683, ingegneri e architetti per i duchi di Savoia}, editor = {Merlotti, Andrea}, publisher = {Campisano editore}, address = {Rom}, isbn = {978-88-98229-57-4}, pages = {141 -- 152}, year = {2016}, language = {en} } @inproceedings{StephanHeuermannPrantner2016, author = {Stephan, Achim and Heuermann, Holger and Prantner, Michael}, title = {Cutting human tissue with novel atmospheric-pressure microwave plasma jet}, series = {46th European Microwave Conference (EuMC)}, booktitle = {46th European Microwave Conference (EuMC)}, publisher = {IEEE}, isbn = {978-2-87487-043-9}, doi = {10.1109/EuMC.2016.7824490}, pages = {902 -- 905}, year = {2016}, language = {en} } @article{NgamgaBialonskiMarwanetal.2016, author = {Ngamga, Eulalie Joelle and Bialonski, Stephan and Marwan, Norbert and Kurths, J{\"u}rgen and Geier, Christian and Lehnertz, Klaus}, title = {Evaluation of selected recurrence measures in discriminating pre-ictal and inter-ictal periods from epileptic EEG data}, series = {Physics Letters A}, volume = {380}, journal = {Physics Letters A}, number = {16}, publisher = {Elsevier}, address = {Amsterdam}, issn = {0375-9601}, doi = {10.1016/j.physleta.2016.02.024}, pages = {1419 -- 1425}, year = {2016}, abstract = {We investigate the suitability of selected measures of complexity based on recurrence quantification analysis and recurrence networks for an identification of pre-seizure states in multi-day, multi-channel, invasive electroencephalographic recordings from five epilepsy patients. We employ several statistical techniques to avoid spurious findings due to various influencing factors and due to multiple comparisons and observe precursory structures in three patients. Our findings indicate a high congruence among measures in identifying seizure precursors and emphasize the current notion of seizure generation in large-scale epileptic networks. A final judgment of the suitability for field studies, however, requires evaluation on a larger database.}, language = {en} } @article{BialonskiCaronSchloenetal.2016, author = {Bialonski, Stephan and Caron, David A. and Schloen, Julia and Feudel, Ulrike and Kantz, Holger and Moorthi, Stefanie D.}, title = {Phytoplankton dynamics in the Southern California Bight indicate a complex mixture of transport and biology}, series = {Journal of Plankton Research}, volume = {38}, journal = {Journal of Plankton Research}, number = {4}, publisher = {Oxford University Press}, address = {Oxford}, issn = {1464-3774}, doi = {10.1093/plankt/fbv122}, pages = {1077 -- 1091}, year = {2016}, abstract = {The stimulation and dominance of potentially harmful phytoplankton taxa at a given locale and time are determined by local environmental conditions as well as by transport to or from neighboring regions. The present study investigated the occurrence of common harmful algal bloom (HAB) taxa within the Southern California Bight, using cross-correlation functions to determine potential dependencies between HAB taxa and environmental factors, and potential links to algal transport via local hydrography and currents. A simulation study, in which Lagrangian particles were released, was used to assess travel times due to advection by prevailing ocean currents in the bight. Our results indicate that transport of some taxa may be an important mechanism for the expansion of their distributions into other regions, which was supported by mean travel times derived from our simulation study and other literature on ocean currents in the Southern California Bight. In other cases, however, phytoplankton dynamics were rather linked to local environmental conditions, including coastal upwelling events. Overall, our study shows that complex current patterns in the Southern California Bight may contribute significantly to the formation and expansion of HABs in addition to local environmental factors determining the spatiotemporal dynamics of phytoplankton blooms.}, language = {en} } @incollection{Bialonski2016, author = {Bialonski, Stephan}, title = {Are interaction clusters in epileptic networks predictive of seizures?}, series = {Epilepsy: The Intersection of Neurosciences, Biology, Mathematics, Engineering, and Physics}, booktitle = {Epilepsy: The Intersection of Neurosciences, Biology, Mathematics, Engineering, and Physics}, publisher = {CRC Press}, isbn = {978-143983886-0}, pages = {349 -- 355}, year = {2016}, language = {en} } @article{BeckerDelfmannDietrichetal.2016, author = {Becker, J{\"o}rg and Delfmann, Patrick and Dietrich, Hanns-Alexander and Steinhorst, Matthias and Eggert, Mathias}, title = {Business Process Compliance Checking — Applying and Evaluating a Generic Pattern Matching Approach for Conceptual Models in the Financial Sector}, series = {Information Systems Frontiers}, volume = {18}, journal = {Information Systems Frontiers}, number = {2}, publisher = {Springer}, address = {Berlin}, issn = {1572-9419}, doi = {10.1007/s10796-014-9529-y}, pages = {359 -- 405}, year = {2016}, abstract = {Given the strong increase in regulatory requirements for business processes the management of business process compliance becomes a more and more regarded field in IS research. Several methods have been developed to support compliance checking of conceptual models. However, their focus on distinct modeling languages and mostly linear (i.e., predecessor-successor related) compliance rules may hinder widespread adoption and application in practice. Furthermore, hardly any of them has been evaluated in a real-world setting. We address this issue by applying a generic pattern matching approach for conceptual models to business process compliance checking in the financial sector. It consists of a model query language, a search algorithm and a corresponding modelling tool prototype. It is (1) applicable for all graph-based conceptual modeling languages and (2) for different kinds of compliance rules. Furthermore, based on an applicability check, we (3) evaluate the approach in a financial industry project setting against its relevance for decision support of audit and compliance management tasks.}, language = {en} } @inproceedings{TeixeiraBouraNiederwestbergMcLeodetal.2016, author = {Teixeira Boura, Cristiano Jos{\´e} and Niederwestberg, Stefan and McLeod, Jacqueline and Herrmann, Ulf and Hoffschmidt, Bernhard}, title = {Development of heat exchanger for high temperature energy storage with bulk materials}, series = {AIP Conference Proceedings}, volume = {1734}, booktitle = {AIP Conference Proceedings}, number = {1}, doi = {10.1063/1.4949106}, pages = {050008-1 -- 050008-7}, year = {2016}, language = {en} } @inproceedings{Finger2016, author = {Finger, Felix}, title = {Comparative Performance and Benefit Assessment of VTOL and CTOL UAVs}, series = {Deutscher Luft- und Raumfahrtkongress (DLRK) 2016, 13.-15.9.2016}, booktitle = {Deutscher Luft- und Raumfahrtkongress (DLRK) 2016, 13.-15.9.2016}, pages = {10 Seiten}, year = {2016}, language = {en} } @article{ZhangHeimbachScheeretal.2016, author = {Zhang, Jin and Heimbach, Tycho and Scheer, Nico and Barve, Avantika and Li, Wenkui and Lin, Wen and He, Handan}, title = {Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling}, series = {Journal of Pharmaceutical Sciences}, volume = {Volume 105}, journal = {Journal of Pharmaceutical Sciences}, number = {Issue 4}, publisher = {Elsevier}, address = {Amsterdam}, issn = {0022-3549}, doi = {doi.org/10.1016/j.xphs.2016.01.021}, pages = {1398 -- 1404}, year = {2016}, abstract = {NVS123 is a poorly water-soluble protease 56 inhibitor in clinical development. Data from in vitro hepatocyte studies suggested that NVS123 is mainly metabolized by CYP3A4. As a consequence of limited solubility, NVS123 therapeutic plasma exposures could not be achieved even with high doses and optimized formulations. One approach to overcome NVS123 developability issues was to increase plasma exposure by coadministrating it with an inhibitor of CYP3A4 such as ritonavir. A clinical boost effect was predicted by using physiologically based pharmacokinetic (PBPK) modeling. However, initial boost predictions lacked sufficient confidence because a key parameter, fraction of drug metabolized by CYP3A4 (ƒₘCYP3A4), could not be estimated with accuracy on account of disconnects between in vitro and in vivo preclinical data. To accurately estimate ƒₘCYP3A4 in human, an in vivo boost effect study was conducted using CYP3A4-humanized mouse model which showed a 33- to 56-fold exposure boost effect. Using a top-down approach, human ƒₘCYP3A4 for NVS123 was estimated to be very high and included in the human PBPK modeling to support subsequent clinical study design. The combined use of the in vivo boost study in CYP3A4-humanized mouse model mice along with PBPK modeling accurately predicted the clinical outcome and identified a significant NVS123 exposure boost (∼42-fold increase) with ritonavir.}, language = {en} } @article{DallasSalphatiGomezZepedaetal.2016, author = {Dallas, Shannon and Salphati, Laurent and Gomez-Zepeda, David and Wanek, Thomas and Chen, Liangfu and Chu, Xiaoyan and Kunta, Jeevan and Mezler, Mario and Menet, Marie-Claude and Chasseigneaux, Stephanie and Decl{\`e}ves, Xavier and Langer, Oliver and Pierre, Esaie and DiLoreto, Karen and Hoft, Carolin and Laplanche, Loic and Pang, Jodie and Pereira, Tony and Andonian, Clara and Simic, Damir and Rode, Anja and Yabut, Jocelyn and Zhang, Xiaolin and Scheer, Nico}, title = {Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model}, series = {Molecular Pharmacology}, volume = {89}, journal = {Molecular Pharmacology}, number = {5}, publisher = {ASPET}, address = {Bethesda, Md.}, issn = {1521-0111}, doi = {10.1124/mol.115.102079}, pages = {492 -- 504}, year = {2016}, abstract = {Breast cancer resistance protein (BCRP) is expressed in various tissues, such as the gut, liver, kidney and blood brain barrier (BBB), where it mediates the unidirectional transport of substrates to the apical/luminal side of polarized cells. Thereby BCRP acts as an efflux pump, mediating the elimination or restricting the entry of endogenous compounds or xenobiotics into tissues and it plays important roles in drug disposition, efficacy and safety. Bcrp knockout mice (Bcrp-/-) have been used widely to study the role of this transporter in limiting intestinal absorption and brain penetration of substrate compounds. Here we describe the first generation and characterization of a mouse line humanized for BCRP (hBCRP), in which the mouse coding sequence from the start to stop codon was replaced with the corresponding human genomic region, such that the human transporter is expressed under control of the murine Bcrp promoter. We demonstrate robust human and loss of mouse BCRP/Bcrp mRNA and protein expression in the hBCRP mice and the absence of major compensatory changes in the expression of other genes involved in drug metabolism and disposition. Pharmacokinetic and brain distribution studies with several BCRP probe substrates confirmed the functional activity of the human transporter in these mice. Furthermore, we provide practical examples for the use of hBCRP mice to study drug-drug interactions (DDIs). The hBCRP mouse is a promising model to study the in vivo role of human BCRP in limiting absorption and BBB penetration of substrate compounds and to investigate clinically relevant DDIs involving BCRP.}, language = {en} }